Top Links You Must Click On
From the Wires
Sobi to list bond loan on NASDAQ OMX Stockholm and publishes prospectus
By: Marketwired .
Nov. 12, 2012 07:04 AM
STOCKHOLM, SWEDEN -- (Marketwire) -- 11/12/12 -- On 26 June 2012 Swedish Orphan Biovitrum AB (Sobi) issued a 5-year senior unsecured bond loan in the total amount of SEK 600 million. Sobi has applied for a listing of the bond loan on NASDAQ OMX Stockholm in accordance with the terms and conditions of the bond loan and prepared a prospectus.
The prospectus has been approved by the Swedish Financial Supervisory Authority and the bond loan is expected to be listed on NASDAQ OMX Stockholm on 16 November 2012. The prospectus is now available on Sobi's webpage http://www.sobi.com/Investors--Media/Bond-Loan/
Swedish Orphan Biovitrum (Sobi)
Sobi is an international healthcare company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients. The product portfolio is primarily focused on inflammation and genetic diseases, with three late stage biological development projects within hemophilia and neonatology. Sobi also markets more than 40 products for companies in the specialty and rare disease space. In 2011, Sobi had revenues of SEK 1.9 billion and around 500 employees. The share (STO: SOBI) is listed on NASDAQ OMX Stockholm. More information is available at www.sobi.com.
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Swedish Orphan Biovitrum AB (publ) via Thomson Reuters ONE
For further information, please contact:
Enterprise Open Source Magazine Latest Stories . . .
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week